Overexpression of miR-132 in normal B cells replicated this finding, upregulating TNF-α and LTa levels, which could be inhibited by resveratrol treatment, a sirtuin-1 activator, indicating a potential mechanism for aberrant inflammatory cytokine production in MS (Miyazaki et al., 2014). This evidence concerns the gene LTA and myeloid sarcoma.